Pfaender M, Casetti P G, Azzolini M, Baldi M L, Valli A
Unit of Anesthesia and Intensive Care, S. Maria del Carmine Hospital, Rovereto (TN), Italy.
Minerva Anestesiol. 2008 Mar;74(3):97-100.
The aim of this paper was to describe a case of massive atenol and nifedipine poisoning, complicated by the co-existence of liver cirrhosis, where standard therapies (fluid replacement, vasopressors and inotropic agents, insulin, glucagon, calcium and bowel decontamination) were ineffective in restoring an adequate heart rate, blood pressure, renal and intestinal blood flow. This led to consequent anuric renal insufficiency and incipient multiple organ failure syndrome (MOFS). The patient recovered completely after Continuous Veno-Venous Hemo-Dia-Filtration (CVVHDF); this treatment removed atenolol from blood, with predicted clearance levels. The patient was a 45-year old female with a history of hypertension, liver cirrhosis, neurological and psychiatric disorders, with a massive atenolol (69.6 microg/mL) and nifedipine (63 ng/mL) overdose. CVVHDF at an ultrafiltration rate of 1 500 mL/h was started on day 1. From day 2 onwards, as the plasma atenolol concentration decreased, the blood pressure rose at a slow but constant rate. On day 5, there was restoration of an adequate blood pressure, which restored both renal and intestinal function, and also improved MOFS. The standard therapeutic approach was ineffective at eliminating both substances from the blood, and the clinical picture became worse due to incipient MOFS. CVVHDF was used in order to maintain the fluid and electrolyte balance and also to clear the beta blocker from the blood. The clearance kinetics of atenolol were consistent with the expected clearance values, on the basis of a CVVHDF ultrafiltration flow of 1 500 mL/h, which corresponds to a creatinine clearance of about 25 mL/min.
本文旨在描述一例大量服用阿替洛尔和硝苯地平中毒的病例,该病例同时合并肝硬化,在此情况下,标准治疗方法(液体复苏、血管加压药和正性肌力药物、胰岛素、胰高血糖素、钙剂及肠道去污)在恢复足够的心率、血压、肾血流量和肠血流量方面均无效。这导致了随后的无尿性肾功能不全和早期多器官功能衰竭综合征(MOFS)。患者在接受持续静脉-静脉血液透析滤过(CVVHDF)治疗后完全康复;该治疗从血液中清除了阿替洛尔,清除水平符合预测值。患者为一名45岁女性,有高血压、肝硬化、神经和精神疾病史,过量服用了大量阿替洛尔(69.6微克/毫升)和硝苯地平(63纳克/毫升)。第1天开始以1500毫升/小时的超滤率进行CVVHDF治疗。从第2天起,随着血浆阿替洛尔浓度下降,血压以缓慢但持续的速度上升。第5天,血压恢复正常,肾功能和肠功能均得以恢复,MOFS也有所改善。标准治疗方法在从血液中清除这两种物质方面无效,且由于早期MOFS,临床情况恶化。使用CVVHDF是为了维持液体和电解质平衡,并从血液中清除β受体阻滞剂。基于1500毫升/小时的CVVHDF超滤流量(相当于肌酐清除率约25毫升/分钟),阿替洛尔的清除动力学与预期清除值一致。